MedTrace Logo

Biomarker of Children With Familial Autoimmune History

NCT01541033 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 58

Last updated 2016-08-19

No results posted yet for this study

Summary

The purpose of this study is to identify biomarkers in this subset of autism patients, design a protein based assay system for screening serum for these biomarkers and confirm that these serum antibodies are still present at one year's time.

Conditions

Sponsors & Collaborators

  • University of Tennessee

    collaborator OTHER

  • Le Bonheur Children's Hospital

    lead OTHER

Principal Investigators

  • Kathryn A McVicar, MD · LeBonheur Children's Medical Center

  • Larry T Reiter, PhD · LeBonheur Children's Medical Center

Eligibility

Min Age
4 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-11-30
Primary Completion
2016-05-31
Completion
2016-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01541033 on ClinicalTrials.gov